Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.
暂无分享,去创建一个
Maurizio Recanatini | Maria Laura Bolognesi | Andrea Cavalli | Vincenza Andrisano | Carlo Melchiorre | A. Cavalli | V. Andrisano | M. Bartolini | M. Recanatini | M. Rosini | M. Bolognesi | C. Melchiorre | L. Valgimigli | Manuela Bartolini | Luca Valgimigli | Michela Rosini
[1] A. Beth,et al. Bis(sulfo-N-succinimidyl) doxyl-2-spiro-5'-azelate: synthesis, characterization, and reaction with the anion-exchange channel in intact human erythrocytes. , 1989, Biochemistry.
[2] Richard Morphy,et al. From magic bullets to designed multiple ligands. , 2004, Drug discovery today.
[3] H. Kozłowski,et al. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis). , 2006, Chemical reviews.
[4] P. Doraiswamy,et al. Metals in our minds: therapeutic implications for neurodegenerative disorders , 2004, The Lancet Neurology.
[5] A. Cavalli,et al. Design, synthesis and biological evaluation of ambenonium derivatives as AChE inhibitors. , 2003, Farmaco.
[6] R. Hider,et al. The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy , 2005, British journal of pharmacology.
[7] Maurizio Recanatini,et al. A small molecule targeting the multifactorial nature of Alzheimer's disease. , 2007, Angewandte Chemie.
[8] J. Sussman,et al. Structure of a complex of the potent and specific inhibitor BW284C51 with Torpedo californica acetylcholinesterase. , 2002, Acta crystallographica. Section D, Biological crystallography.
[9] P Willett,et al. Development and validation of a genetic algorithm for flexible docking. , 1997, Journal of molecular biology.
[10] L. Baum,et al. Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. , 2004, Journal of Alzheimer's disease : JAD.
[11] Andrea Cavalli,et al. AClAP, Autonomous hierarchical agglomerative Cluster Analysis based protocol to partition conformational datasets , 2006, ISMB.
[12] P. Carlier,et al. Effects of bis(7)-tacrine, a novel anti-Alzheimer's agent, on rat brain AChE. , 1999, Neuroreport.
[13] P. Carlier,et al. Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions. , 1999, Journal of medicinal chemistry.
[14] Y. Pang,et al. A Potent and Selective Tacrine Analog—Biomembrane Permeation and Physicochemical Characterization , 2005, Pharmaceutical development and technology.
[15] V. Andrisano,et al. beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. , 2003, Biochemical pharmacology.
[16] D. Dittmer,et al. Models for the pyridine nucleotide coenzymes. Synthesis and properties of bridged dinicotinamide derivatives. , 1973, Journal of Organic Chemistry.
[17] George Hsiao,et al. Homodimeric tacrine congeners as acetylcholinesterase inhibitors. , 2002, Journal of medicinal chemistry.